All Stories

  1. Associations Among Binge Eating Behaviors, Emotion Regulation, and Chronotype in Female Greek University Students
  2. The underlying cause for the metabolic syndrome is disregulation of the circadian clock
  3. Red white and blue – bright light effects in a diurnal rodent model for seasonal affective disorder
  4. Is the amphetamine based model for mania valid?
  5. The importance of reproducibility in animal models
  6. How to analyze data from behavioral test batteries in rodents
  7. Sex effects in repeated protocol of the forced swim test
  8. Reletionship between circadian rhythms, diabetes and depression
  9. Individual responses of rodents in modelling of affective disorders and in their treatment: prospective review
  10. Interactions between stress and lithium in behavior of mice
  11. Meta-analysis of antidepressants effects in the forced swim test
  12. Effects of repeated asenapine in a battery of tests for anxiety-like behaviours in mice
  13. Bipolar disorder
  14. Beware of your mouse strain; differential effects of lithium on behavioral and neurochemical phenotypes in Harlan ICR mice bred in Israel or the USA
  15. Partial effects of the protein kinase C inhibitor chelerythrine in a battery of tests for manic-like behavior in black Swiss mice
  16. Using the diurnal Degu to model seasonal depression
  17. Oral carbamazepine effects in mice
  18. Estrogen effects on the forced swim test differ in two outbred rat strains
  19. Behavioral differences in black Swiss mice from separate colonies
  20. Effects of morning compared with evening bright light administration to ameliorate short-photoperiod induced depression- and anxiety-like behaviors in a diurnal rodent model
  21. Circadian rhythms and depression: Human psychopathology and animal models
  22. Modeling mania: Further validation for Black Swiss mice as model animals
  23. Amphetamine-Induced Conditioned Place Preference and Modeling Domains of Bipolar Disorder
  24. Inconsistent effects of photoperiod manipulations in tests for affective-like changes in mice
  25. Antidepressants Reverse Short-Photoperiod-Induced, Forced Swim Test Depression-Like Behavior in the Diurnal Fat Sand Rat: Further Support for the Utilization of Diurnal Rodents for Modeling Affective Disorders
  26. Antidepressant-like effects of the active acidic polysaccharide portion of ginseng in mice
  27. It is darkness and not light: Depression-like behaviors of diurnal unstriped Nile grass rats maintained under a short photoperiod schedule
  28. Strain-specific battery of tests for domains of mania: effects of valproate, lithium and imipramine
  29. Strategies for the Development of Animal Models for Bipolar Disorder: New Opportunities and New Challenges
  30. Effects of bright light treatment on depression- and anxiety-like behaviors of diurnal rodents maintained on a short daylight schedule
  31. A possible utilization of the mice forced swim test for modeling manic-like increase in vigor and goal-directed behavior
  32. Attenuation of high sweet solution preference by mood stabilizers: A possible mouse model for the increased reward-seeking domain of mania
  33. Mice Models for the Manic Pole of Bipolar Disorder
  34. We are in the dark here: induction of depression- and anxiety-like behaviours in the diurnal fat sand rat, by short daylight or melatonin injections
  35. Developing Therapeutics for Bipolar Disorder (BPD): From Animal Models to the Clinic
  36. Prospects for the Development of Animal Models for the Study of Bipolar Disorder
  37. β-Catenin Overexpression in the Mouse Brain Phenocopies Lithium-Sensitive Behaviors
  38. Different behaviors and different strains: Potential new ways to model bipolar disorder
  39. Animal models of bipolar disorder and mood stabilizer efficacy: A critical need for improvement
  40. Protein Kinase C Inhibition by Tamoxifen Antagonizes Manic-Like Behavior in Rats: Implications for the Development of Novel Therapeutics for Bipolar Disorder
  41. Targeting Glycogen Synthase Kinase-3 in the CNS: Implications for the Development of New Treatments for Mood Disorders
  42. Establishment of a Battery of Simple Models for Facets of Bipolar Disorder: A Practical Approach to Achieve Increased Validity, Better Screening and Possible Insights into Endophenotypes of Disease
  43. Cellular Plasticity Cascades: Genes-To-Behavior Pathways in Animal Models of Bipolar Disorder
  44. Chronic oral administration of ginseng extract results in behavioral change but has no effects in mice models of affective and anxiety disorders
  45. Inflammatory-mediated model of cerebral palsy with developmental sequelae
  46. Epi-inositol is ineffective in Porsolt Forced Swim Test model of depression
  47. AR-A014418, a selective GSK-3 inhibitor, produces antidepressant-like effects in the forced swim test
  48. No phenotype associated with established lipopolysaccharide model for cerebral palsy
  49. Inflammatory-mediated model of cerebral palsy with developmental sequelae
  50. Reply to "Smoking in Bipolar and Schizophrenic Patients"
  51. Chronic inositol treatment reduces depression‐like immobility of Flinders Sensitive Line rats in the forced swim test
  52. Chronic inositol treatment reduces depression-like immobility of Flinders Sensitive Line rats in the forced swim test
  53. Smoking Habits in Bipolar and Schizophrenic Outpatients in Southern Israel
  54. Transcranial magnetic stimulation in an amphetamine hyperactivity model of mania
  55. Mechanisms of Inositol Effects on Behavior
  56. The effects of inositol treatment in animal models of psychiatric disorders
  57. Inmate Argot as an Expression of Prison Subculture: The Israeli Case
  58. Epi-inositol: A potential antidepressant
  59. Animal Models of Bipolar Disorder: From a Single Episode to Progressive Cycling Models
  60. Epi-Inositol and inositol depletion: Two new treatment approaches in affective disorder
  61. Effect of inositol treatment on the behavior of rhesus monkeys: Preliminary results
  62. Chronic epi-inositol has an anxiolytic-like effect in the plus-maze model in rats
  63. Keeping the Body Straight in the Unconstrained Locomotion of Normal and Dopamine-Stimulant-Treated Rats
  64. Associational and nonassociational mechanisms in locomotor sensitization to the dopamine agonist quinpirole
  65. Perseveration without hyperlocomotion in a spontaneous alternation task in rats sensitized to the dopamine agonist quinpirole
  66. Effects of dose and interdose interval on locomotor sensitization to the dopamine agonist quinpirole
  67. Longlasting consequences of chronic treatment with the dopamine agonist quinpirole for the undrugged behavior of rats
  68. Bipolar disorder